Civic AI
Procurement intelligence
Federal contract award
THE PURPOSE OF THIS NO COST MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE FOR CLIN0001 THROUGH SEPTEMBER 30, 2031, UPDATES ARTICLE V: AGREEMENT ADMINISTRATION, AND ARTICLE VII: OBLIGATION AND PAYMENT, SECTION B.
BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL · Department of Health and Human Services
- Value
- $92,501,232
- Start
- Sep 30, 2024
- End
- Sep 30, 2031
- Action date
- Apr 24, 2026
- PIID
- 75A50124C00033
- Status
- active
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- —
- Award type
- DEFINITIVE CONTRACT
Description
THE PURPOSE OF THIS NO COST MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE FOR CLIN0001 THROUGH SEPTEMBER 30, 2031, UPDATES ARTICLE V: AGREEMENT ADMINISTRATION, AND ARTICLE VII: OBLIGATION AND PAYMENT, SECTION B.
Need modifications, related awards, and vendor peers? Open the full award workspace.